These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico. Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888 [TBL] [Abstract][Full Text] [Related]
3. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials. Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638 [TBL] [Abstract][Full Text] [Related]
4. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain. Lemire S Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176 [TBL] [Abstract][Full Text] [Related]
5. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease]. Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153 [TBL] [Abstract][Full Text] [Related]
6. Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain. Hewson EG; Sinclair JW; Dalton CB; Richter JE Am J Med; 1991 May; 90(5):576-83. PubMed ID: 2029015 [TBL] [Abstract][Full Text] [Related]
7. Ambulatory pH: monitoring with a wireless system. Schneider JH; Kramer KM; Königsrainer A; Granderath FA Surg Endosc; 2007 Nov; 21(11):2076-80. PubMed ID: 17484003 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980 [TBL] [Abstract][Full Text] [Related]
10. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure. Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571 [TBL] [Abstract][Full Text] [Related]
12. Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux. Oelschlager BK; Chang L; Pope CE; Pellegrini CA J Surg Res; 2005 Sep; 128(1):55-60. PubMed ID: 16115493 [TBL] [Abstract][Full Text] [Related]
13. Esophageal mucosal mast cell infiltration and changes in segmental smooth muscle contraction in noncardiac chest pain. Park SW; Lee H; Lee HJ; Chung H; Park JC; Shin SK; Lee SK; Lee YC Dis Esophagus; 2015; 28(6):512-9. PubMed ID: 24766344 [TBL] [Abstract][Full Text] [Related]
19. [pHmetry and manometry of the esophagus in patients with pain of the angina type and a normal angiography]. Thévenet P; Gosselin A; Bourdonnec C; Gosselin M; Bretagne JF; Gastard J; Lebars R Gastroenterol Clin Biol; 1988 Feb; 12(2):111-7. PubMed ID: 3366313 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain]. Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]